Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study

Introduction: Immune checkpoint inhibitor (ICI) therapy is markedly improving the prognosis of patients with several types of cancer. On the other hand, the growth in the use of these drugs in oncology is associated with an increase in multiple immune-related adverse events (irAEs), whose optimal pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Les, Iñigo, Pérez-Francisco, Inés, Cabero, María, Sánchez, Cristina, Hidalgo, María, Teijeira, Lucía, Arrazubi, Virginia, Domínguez, Severina, Anaut, Pilar, Eguiluz, Saioa, Elejalde, Iñaki, Herrera, Alberto, Martínez, Mireia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198493/
https://www.ncbi.nlm.nih.gov/pubmed/35721217
http://dx.doi.org/10.3389/fphar.2022.894550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198493/
https://www.ncbi.nlm.nih.gov/pubmed/35721217
http://dx.doi.org/10.3389/fphar.2022.894550

Ejemplares similares